Nicobrand
United Kingdom 34 employees Updated 9 July 2026
Nicobrand is an API manufacturer based in United Kingdom. It holds 3 active US drug master files and 2 valid CEPs across a filed portfolio of 2 molecules. Its GMP standing is certified by MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 3 June 2021 as VAI.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 3 June 2021 VAI US FDA
- 11 December 2014 NAI US FDA
- 7 April 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Coleraine, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3002807711 |
What they file, and where
| Molecule | Regulators | Docs |
| Nicotine | EDQM, US FDA | 4 |
| Nicotine Resinate | EDQM | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MHRA (UK) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Nicobrand comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 3 June 2021.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates